Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

polyneuropathy News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

Experts from the German Society of Amyloid Diseases and the German Neurological Society have reached a consensus on the disease-modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy. This consensus aims to guide clinical practice and improve patient outcomes in Germany.

A recent study evaluates the effectiveness of ChatGPT in diagnosing and managing complex polyneuropathies compared to neurologists. The analysis utilizes real-world cases, highlighting the potential of AI in enhancing clinical decision-making.

A case study reports successful treatment of severe polyneuropathy in a patient with HIV-negative human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin. This finding may inform future therapeutic strategies for similar cases.

Not rare diseases news,news about your rare disease.

Earlier

Experts from the German Society of Amyloid Diseases and the German Neurological Society have reached a consensus on the disease-modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy. This consensus aims to guide clinical practice and improve patient outcomes in Germany.

A recent study evaluates the effectiveness of ChatGPT in diagnosing and managing complex polyneuropathies compared to neurologists. The analysis utilizes real-world cases, highlighting the potential of AI in enhancing clinical decision-making.

A case study reports successful treatment of severe polyneuropathy in a patient with HIV-negative human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin. This finding may inform future therapeutic strategies for similar cases.

Not rare diseases news,
news about your rare disease.